220 results

MedTechEurope_FF_SMEs_2021
Research & Innovation

Posted on 23.06.2021

MedTech: a partner in building a research-oriented, innovative, and resilient Europe

The medical technology sector welcomes the European Commission’s 3rd edition of the EU Research and Innovation Days (R&I Days). This event could not have come at a more important time, as this year marks the official launch of Horizon Europe, the EU’s most ambitious research and innovation program to date. The response to the Covid-19 […]

By Patrick Boisseau Director Research and Innovation, MedTech Europe

shutterstock_1337163632
Value

Posted on 30.04.2021

Paving the Path Ahead for MedTech: Innovation, Health Equity and Global Collaboration

More than a year ago, COVID-19 swept across the world, sending us all into lockdown as we battled the pandemic. Today, as we gradually emerge from the impact and experiences of the past year, I am proud and inspired by how resilient we have been and our ability to find new ways of connecting with […]

By Ashley McEvoy Executive Vice President, Worldwide Chair, Johnson & Johnson MedTech

shutterstock_1569192532
Global

Posted on 19.04.2021

Healthcare’s future starts now

As the old saying goes, making predictions can be difficult – especially about the future. If you need evidence of this, think how you might have answered the question ‘Where do you see yourself in five years’ time?’ if you had been asked in 2016.  But while the pandemic has delivered a harsh lesson in […]

By Stuart Silk Board Member MedTech Europe

shutterstock_578337865
Ethics

Posted on 25.03.2021

New training video boosts global compliance – and public confidence

Bringing innovative medical technology to patients around the world is a priority for the medtech industry. This task often relies on a wide network of third-party intermediaries and distributors. While third parties provide valuable local knowledge, logistics and skills, it is important to appreciate that everyone working on behalf of medtech companies is bound by […]

By Aline Lautenberg General Counsel and Director General Legal & Compliance, MedTech Europe

shutterstock_1920759539
COVID-19

Posted on 25.02.2021

The impact of the pandemic on people living with rare diseases

Almost 12 months after the WHO declared a global COVID-19 pandemic, people with rare diseases can reflect on a turbulent year – even if there are some positive lessons to be learned in how services are delivered. While the pandemic continues, most reflections on the crisis come to a common conclusion: everyone suffered, but not […]

By Sandra Courbier Social Research Director - Rare Barometer Programme Lead

shutterstock_1357664711
COVID-19

Posted on 26.10.2020

COPD & COVID-19: Pandemic must prompt shift to connected care

For people living with chronic obstructive pulmonary disease (COPD), a long-term lung illness, COVID-19 is having a major impact. The pandemic has disrupted traditional models of care and put vulnerable patients at risk. Keeping patients out of hospital – by reducing scheduled visits and avoiding emergency admissions – has become the top priority.  A silver […]

By Odile Bigaignon Vice President, EMEA Marketing at ResMed

shutterstock_210964246
COVID-19

Posted on 26.10.2020

The implications of COVID-19 on recruiting in the Life Science sector

We’re at the heart of the global response to COVID-19, a powerful reminder of our mission to enable our customers to make the world healthier,cleaner and safer. What’s driving us every day is the feeling that there is a meaning to our work over and beyond the reward of the paycheck. What’s compelling now is […]

By Noel Brown Global Head of Talent Attraction & Acquisition at Thermo Fisher Scientific

shutterstock_1498583432
Research & Innovation

Posted on 21.09.2020

EU Health PPP: a new era for medtech companies

For decades, companies in the medtech and pharma sectors have delivered healthcare innovations separately – collaboration has been limited. However, we know that this is not how patients experience healthcare. In the real world, diagnostics, devices, medicines, vaccines and digital tools combine to keep people healthy and to treat those who are unwell.  This reality […]

By Philippe Cleuziat Senior Director, R&D Department Open Innovation & Partnerships at bioMerieux

shutterstock_739595833
COVID-19

Posted on 14.09.2020

Why COVID-19 makes value-based healthcare more critical than ever?

Healthcare should put patients at the heart of decision-making, while delivering benefits for society as efficiently as possible. This, I believe, was clear before the pandemic. However, the additional strain under which our systems must operate at present, as well as additional demands for resources, make the case for value-based healthcare (VBHC) stronger than ever […]

By Christophe Duhayer Managing Director, Johnson & Johnson Medical Devices France